WebMar 29, 2024 · Citation, DOI, disclosures and article data. Cholangiocarcinomas (commonest type of bile duct cancers) are malignant epithelial tumors arising from the biliary tree, excluding the gallbladder or ampulla of Vater. Cholangiocarcinoma is the third most common primary hepatobiliary malignancy after hepatocellular carcinoma (HCC) and … WebOct 16, 2024 · Thus, we retrospectively analyzed 72 Chinese patients with CCA who had received genetic testing of targeted capture sequencing. A total of 2152 somatic ... 26.39% were distal extrahepatic CCA, and 16.67% were intrahepatic CCA. At the same time, most patients (63.89%, 46/72) were in the T2 phase. More than half of the patients ...
Current Surgical Management of Peri-Hilar and Intra-Hepatic
WebiCCA is a subset of cholangiocarcinoma (CCA) CCA, the most common primary malignancy of the bile duct, is classified by anatomic origin into iCCA and extrahepatic CCA (eCCA). eCCA is further divided into 2 types 1-3: Perihilar CCA (pCCA) (also termed "Klatskin’s tumor") Distal CCA (dCCA) 3. iCCA originates in the bile ducts within the liver.1. WebJul 7, 2024 · Cholangiocarcinoma (CCA) is a heterogeneous group of neoplasms of the bile ducts and represents the second most common hepatic cancer after hepatocellular carcinoma; it is sub-classified as intrahepatic cholangiocarcinoma (iCCA) and extrahepatic cholangiocarcinoma (eCCA), the latter comprising both perihilar cholangiocarcinoma … reasors store count
Cholangiocarcinoma (bile duct cancer) - Diagnosis and treatment
WebApr 12, 2024 · Cholangiocarcinoma (CCA) is a relatively rare cancer associated with an extremely poor prognosis. Based on the anatomical location, CCA is usually classified as intrahepatic cholangiocarcinoma (iCCA) or extrahepatic cholangiocarcinoma (eCCA), which includes perihilar cholangiocarcinomas (pCCAs) and distal cholangiocarcinomas … WebApr 11, 2024 · The research team identified 96,151 cases of hepatocellular carcinoma and 13,611 cases of intrahepatic cholangiocarcinoma. In terms of sex, 76.3% of hepatocellular carcinoma cases were male, and 23.7% were female; in intrahepatic cholangiocarcinoma, the figures were 50.7% and 49.3%, respectively. This indicates that there is a stronger ... WebJan 17, 2024 · Purpose FGFR genetic aberrations (GAs) occur in an estimated 10% to 16% of intrahepatic cholangiocarcinomas (CCAs). The natural history of CCA with FGFR GAs, the prognostic role of coexisting GAs, and the outcome with FGFR-targeted inhibitors are unknown. Patients and Methods Patients with CCA with FGFR GAs were identified using … reasors south memorial